Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance

Go back to Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance

Truist is bullish on this Managed Healthcare stock

April 24, 2026 1:00 PM EDT

Truist reiterated its Buy rating on one managed healthcare stock in a note this week following what the firm called a solid first-quarter earnings report.

Analyst David MacDonald said Health Benefits drove the bulk of Elevance Health's (NYSE: ELV) beat, with better-than-expected performance across Medicaid, Medicare and Commercial segments. He maintained $375 price target... More

Truist is bullish on this Managed Healthcare stock

April 24, 2026 1:00 PM EDT

Truist reiterated its Buy rating on one managed healthcare stock in a note this week following what the firm called a solid first-quarter earnings report.

Analyst David MacDonald said Health Benefits drove the bulk of Elevance Health's (NYSE: ELV) beat, with better-than-expected performance across Medicaid, Medicare and Commercial segments. He maintained $375 price target... More

Elevance Health Inc. (ELV) Tops Q1 EPS by $1.74, Beats on Revenue; Offers FY26 EPS Guidance

April 22, 2026 6:01 AM EDT

Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $12.58, $1.74 better than the analyst estimate of $10.84. Revenue for the quarter came in at $49.5 billion versus the consensus estimate of $48.2 billion.

GUIDANCE:

Elevance Health Inc. sees FY2026 EPS of $26.75, versus the consensus of... More